Invention Grant
US07671017B2 Use of a combination of cyclosporine and pegylated interferon for treating hepatitis C (HCV)
失效
使用环孢菌素和聚乙二醇化干扰素的组合治疗丙型肝炎（HCV）
- Patent Title: Use of a combination of cyclosporine and pegylated interferon for treating hepatitis C (HCV)
- Patent Title (中): 使用环孢菌素和聚乙二醇化干扰素的组合治疗丙型肝炎（HCV）
-
Application No.: US11572110Application Date: 2005-07-13
-
Publication No.: US07671017B2Publication Date: 2010-03-02
- Inventor: Catherine Cornu-Artis , Guylaine Vachon , Yoko Uryuhara , Kazuo Asakawa , Reinhild Elisabeth Mertes , Shinsyou Yoshiba
- Applicant: Catherine Cornu-Artis , Guylaine Vachon , Yoko Uryuhara , Kazuo Asakawa , Reinhild Elisabeth Mertes , Shinsyou Yoshiba
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Leslie Fischer
- Priority: EP04016583 20040714
- International Application: PCT/EP2005/007633 WO 20050713
- International Announcement: WO2006/005610 WO 20060119
- Main IPC: A61K31/7042
- IPC: A61K31/7042 ; A61K38/00 ; A61K38/13 ; A61K38/21
Abstract:
A method of treating a patient having a HCV infection which method comprises administering to said patient a cyclosporin A or a cyclosporin A derivative in association with a conjugate of interferon to a water-soluble polymer in an amount effective to alleviate or eliminate one or more of the signs or symptoms of HCV.
Public/Granted literature
- US20080138316A1 Use of a Combination of Cyclosporine and Pegylated Interferon for Treating Hepatitis C (Hcv) Public/Granted day:2008-06-12
Information query
